Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. "Gilead delivered another exceptionally ...

The head of the UN Aids agency has said the number of new HIV infections could jump by more than six times by 2029 if American support for the ...

Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first ...

The author’s debut novel for adults, The Boy from the Sea, beautifully evokes the life of a fisherman in a small town and ...

Gilead Sciences achieved a 14% increase in market capitalisation due to the recently submitted a new drug application to the FDA for lenacapavir, a twice-yearly injectable HIV-1 caspid inhibitor for ...

TEANECK, N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims ...

Copyright 2025 The Associated Press. All Rights Reserved. Fianna Fail leader Micheal Martin, right, and Fine Gael’s Simon Harris talk to the media outside the ...

Ireland has delayed choosing its new prime minister after a row over speaking rights sparked angry scenes in parliament. The Irish Parliament, called the Dail, had this morning convened to ...

Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing. Gilead had reached an inflection point ...